REG - HSBC ETFs PLC - Director Appointment
RNS Number : 4261FHSBC ETFs PLC15 July 202115 July 2021
HSBC ETFs plc
(the "Company")
Director Appointment
The Company wishes to announce the following change to the composition of its Board of Directors with effect from Monday, 02 August 2021:
- The appointment of a new Non-Executive Director, namely Peter Blessing (the "New Director").
The New Director is or was a director of the following companies during the last five years:
Current Directorships
Previous Directorships
Albemarle Alternative Funds plc
Buckingham Realty 4 Limited
Albemarle Funds plc
Provide VR 2003-1 Public Limited Company
Apsley Fund ICAV
Proscore VR 2005-1 PLC
Allianz Jewel ICAV
Cornerstone titan 2005-1 Public Limited Company
Citco Fund Services (Dublin) Limited
Hilcrest investors DAC
CZ Capital ICAV
Blackoak Capital Limited
DIE Ireland ICAV
Calico Finance Number One DAC
DIG Ireland ICAV
Fastnet Securities 9 DAC
TaSE Hotel Ireland ICAV
Sealink Funding DAC
WIIS Ireland ICAV
Cairn High Grade CDS CDO 1 PLC
Dimensional Funds plc
Pelican Mortgages No.2 PLC
Dimensional Funds II plc
Magellan Mortgages No. 2 PLC
First Sentier Investments (Ireland) Limited
Pelican Mortgages No. 1 PLC
HSBC Global Funds ICAV
Marriott International Funds plc
Payden & Rygel Global Funds plc
Philos Alternative Edge Funds plc
Smith & Williamson Investment Fund plc
Smith & Williamson Management (Ireland) Limited
Vanguard Funds plc
Vanguard Group (Ireland) Limited
Vanguard Investment Series plc
Dim Ireland ICAV
WIIV Ireland ICAV
There is no further information required to be disclosed pursuant to Listing Rule 9.6.13 (2) - (6) of the Listing Rules of the Financial Conduct Authority in respect of the New Director.
Further Information:
HSBC ETFs plc
25/28 North Wall Quay
IFSC, Dublin 1
+353 1 635 6000*
J&E Davy (Sponsor)
Brian Garrahy
+353 1 679 6363*
* Calls may be recorded
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDBOASFDFIIEFSEIW
Recent news on Wam Capital
See all newsREG - Greencare Capital - Directorate Changes
AnnouncementRCS - All Active Asset Cap - Company Update
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 28/03/2022
AnnouncementRCS - All Active Asset Cap - Interim Results
Announcement